Explore › Intervention › empirical dietary indices for insulin resistance and hyperinsulinemia
Intervention

empirical dietary indices for insulin resistance and hyperinsulinemia

Also known as: Higher adherence to empirical dietary indices for insulin resistance (EDIR) and hyperinsulinemia (EDIH) (per 1-SD increase in pre-diagnosis score; derived from food groups predictive of triglyceride:HDL ratio and C-peptide, respectively)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
Multiple Myeloma1
outcomes
MM-specific mortality1
populations
Multiple Myeloma Patients1
studys
PMC74237191

Findings (27)

None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →
None
decline

Multiple myeloma patients with higher pre-diagnosis insulinemic dietary scores had 16-17% higher MM-specific mortality per 1-SD increase, suggesting that diets promoting insulin resistance or hyperins

Effect: decline; HR 1.16 (EDIR); HR 1.17 (EDIH); CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01 to 1.35 (EDIH)

Size: HR 1.16 (EDIR); HR 1.17 (EDIH) CI: 95% CI 1.02 to 1.33 (EDIR); 95% CI 1.01
PMC7423719
Finding details → · Paper → · Graph →

Papers (1)